Wenwen Du

2.1k total citations
52 papers, 1.5k citations indexed

About

Wenwen Du is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Wenwen Du has authored 52 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 11 papers in Surgery and 10 papers in Molecular Biology. Recurrent topics in Wenwen Du's work include Renal Transplantation Outcomes and Treatments (8 papers), Transplantation: Methods and Outcomes (8 papers) and Lung Cancer Treatments and Mutations (7 papers). Wenwen Du is often cited by papers focused on Renal Transplantation Outcomes and Treatments (8 papers), Transplantation: Methods and Outcomes (8 papers) and Lung Cancer Treatments and Mutations (7 papers). Wenwen Du collaborates with scholars based in China, United States and Taiwan. Wenwen Du's co-authors include Yuanyuan Zeng, Zeyi Liu, Jianjie Zhu, Jiancheng Wang, Xueqing Wang, Hua Zhang, Lan Yuan, Xuan Zhang, Bing He and Jianan Huang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Biomaterials.

In The Last Decade

Wenwen Du

44 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wenwen Du China 17 663 570 354 289 257 52 1.5k
Yihan Yao China 13 286 0.4× 710 1.2× 255 0.7× 469 1.6× 171 0.7× 35 1.8k
Ling Bai China 17 317 0.5× 461 0.8× 256 0.7× 243 0.8× 106 0.4× 32 1.1k
Wei Xia China 20 331 0.5× 742 1.3× 195 0.6× 227 0.8× 236 0.9× 44 1.6k
Zhiwen Yao China 13 498 0.8× 551 1.0× 90 0.3× 452 1.6× 194 0.8× 32 1.9k
Chao Qin China 24 231 0.3× 672 1.2× 121 0.3× 424 1.5× 177 0.7× 69 1.5k
Xuefeng Xia China 22 392 0.6× 545 1.0× 503 1.4× 72 0.2× 205 0.8× 71 1.6k
Sanam Sadreddini Iran 16 281 0.4× 734 1.3× 265 0.7× 150 0.5× 106 0.4× 25 1.4k
Ran Tian China 24 320 0.5× 1.0k 1.8× 223 0.6× 384 1.3× 163 0.6× 40 1.9k
Shanzhou Duan China 19 261 0.4× 529 0.9× 141 0.4× 207 0.7× 255 1.0× 40 1.2k

Countries citing papers authored by Wenwen Du

Since Specialization
Citations

This map shows the geographic impact of Wenwen Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenwen Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenwen Du more than expected).

Fields of papers citing papers by Wenwen Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenwen Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenwen Du. The network helps show where Wenwen Du may publish in the future.

Co-authorship network of co-authors of Wenwen Du

This figure shows the co-authorship network connecting the top 25 collaborators of Wenwen Du. A scholar is included among the top collaborators of Wenwen Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenwen Du. Wenwen Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Xiting, Wenqian Chen, Wenwen Du, Pengmei Li, & Xiaoxing Wang. (2025). Application of artificial intelligence and machine learning in lung transplantation: a comprehensive review. Frontiers in Digital Health. 7. 1583490–1583490. 1 indexed citations
2.
3.
Du, Wenwen, Wenqian Chen, Dan Zhang, et al.. (2025). Establishment and validation of a predictive nomogram for voriconazole-associated liver injury in lung transplant patients. International Journal of Clinical Pharmacy. 47(5). 1416–1426.
4.
Murataeva, Natalia, Wenwen Du, Ruth A. Ross, et al.. (2024). CB1 Receptor Negative Allosteric Modulators as a Potential Tool to Reverse Cannabinoid Toxicity. Molecules. 29(8). 1881–1881. 2 indexed citations
5.
Du, Wenwen, Xiaoxing Wang, Dan Zhang, & Xianbo Zuo. (2024). Exploratory associations of tacrolimus exposure and clinical outcomes after lung transplantation: A retrospective, single center experience. European Journal of Clinical Pharmacology. 80(5). 747–757. 2 indexed citations
6.
Murataeva, Natalia, et al.. (2024). Cannabinoid regulation of sex-dependent murine odorant-stimulated salivation. Scientific Reports. 14(1). 26720–26720.
7.
Murataeva, Natalia, et al.. (2024). Murine vaginal secretory responses to a male volatile chemical messenger. Scientific Reports. 14(1). 27707–27707.
8.
Chen, Wenqian, Xiaoxing Wang, Xiaoxing Wang, et al.. (2023). A highly sensitive method for determination of tacrolimus in peripheral blood mononuclear cells by nano liquid chromatography–high resolution accurate mass spectrometry. Journal of Chromatography A. 1706. 464259–464259. 1 indexed citations
9.
Wang, Anqi, Tingting Cai, Yue Li, et al.. (2022). Integrin α3/α6 and αV are implicated in ADAM15-activated FAK and EGFR signalling pathway individually and promote non-small-cell lung cancer progression. Cell Death and Disease. 13(5). 486–486. 19 indexed citations
10.
Huang, Renwei, Jiating Zhao, Faxing Wang, et al.. (2022). Study on the relationship among typhoon, climate change, and acute Stanford type A aortic dissection in southern of Zhejiang in China. General Thoracic and Cardiovascular Surgery. 71(2). 113–120. 2 indexed citations
11.
Du, Wenwen, Xiaoxing Wang, Dan Zhang, et al.. (2021). The impact of cytochrome P450 3A5 genotype on early tacrolimus metabolism and clinical outcomes in lung transplant recipients. International Journal of Clinical Pharmacy. 44(2). 418–427. 2 indexed citations
12.
Zhu, Jianjie, Tingting Cai, Wenwen Du, et al.. (2021). CD151 drives cancer progression depending on integrin α3β1 through EGFR signaling in non-small cell lung cancer. Journal of Experimental & Clinical Cancer Research. 40(1). 192–192. 40 indexed citations
13.
Huang, Lüping, Qinxue Dai, Anqi Zhang, et al.. (2020). Astrocytic Yes-associated protein attenuates cerebral ischemia-induced brain injury by regulating signal transducer and activator of transcription 3 signaling. Experimental Neurology. 333. 113431–113431. 17 indexed citations
14.
Fu, Yulong, Yang Zhang, Zhe Lei, et al.. (2020). Abnormally activated OPN/integrin αVβ3/FAK signalling is responsible for EGFR-TKI resistance in EGFR mutant non-small-cell lung cancer. Journal of Hematology & Oncology. 13(1). 169–169. 86 indexed citations
15.
Xia, Rui, Min Yang, Xiaorui Fu, et al.. (2020). Differential Requirement of Beclin 1 for Regulating the Balance of Naïve and Activated CD4+ T Cells. Frontiers in Cell and Developmental Biology. 8. 834–834. 3 indexed citations
16.
Yang, Min, Wenwen Du, Shaoxian Wu, et al.. (2020). Checkpoint molecules coordinately restrain hyperactivated effector T cells in the tumor microenvironment. OncoImmunology. 9(1). 1708064–1708064. 37 indexed citations
17.
Qi, Ying, et al.. (2018). In vitro inhibition of proliferation, migration and epithelial-mesenchymal transition of human lens epithelial cells by fasudil. International Journal of Ophthalmology. 11(8). 1253–1257. 8 indexed citations
18.
He, Bing, Wenwen Du, Wei Qu, et al.. (2013). The transport mechanisms of polymer nanoparticles in Caco-2 epithelial cells. Biomaterials. 34(25). 6082–6098. 194 indexed citations
19.
He, Bing, Wenwen Du, Chao Yu, et al.. (2013). The transport pathways of polymer nanoparticles in MDCK epithelial cells. Biomaterials. 34(17). 4309–4326. 105 indexed citations
20.
Zheng, Nan, Wenbing Dai, Wenwen Du, et al.. (2012). A Novel Lanreotide-Encoded Micelle System Targets Paclitaxel to the Tumors with Overexpression of Somatostatin Receptors. Molecular Pharmaceutics. 9(5). 1175–1188. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yihan Yao Breakdown of academic impact, for papers by Ling Bai Breakdown of academic impact, for papers by Wei Xia Breakdown of academic impact, for papers by Zhiwen Yao Breakdown of academic impact, for papers by Chao Qin Breakdown of academic impact, for papers by Xuefeng Xia Breakdown of academic impact, for papers by Sanam Sadreddini Breakdown of academic impact, for papers by Ran Tian Breakdown of academic impact, for papers by Shanzhou Duan
Rankless by CCL
2026